Company Profiles

driven by the PitchBook Platform

SetPoint Medical

Description

Developer of neuromodulation technology for the treatment of chronic inflammatory diseases. The company provides a scientific platform based on the inflammatory reflex mechanism by which the central nervous system regulates the immune system. It also consists of an implantable miniature neuromodulation device, wireless charger and iPad prescription pad application that uses vagus nerve stimulation to activate the body’s natural inflammatory reflex, which produces a systemic anti-inflammatory effect.

2006

Founded

PRIVATE

Status

11-50

Employees

Series C1

Latest Deal Type

$15.1M

Latest Deal Amount

$60.3M

Total Amount Raised

Description

Developer of neuromodulation technology for the treatment of chronic inflammatory diseases. The company provides a scientific platform based on the inflammatory reflex mechanism by which the central nervous system regulates the immune system. It also consists of an implantable miniature neuromodulation device, wireless charger and iPad prescription pad application that uses vagus nerve stimulation to activate the body’s natural inflammatory reflex, which produces a systemic anti-inflammatory effect.

Website:

www.setpointmedical.com

Formerly Known As

Innovative Metabolics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Other Healthcare Technology Systems
Biotechnology

Primary Office

28368 Constellation Road Suite 300 Valencia, CA 91355United States +1 (661) 750-6140
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore SetPoint Medical's full profile, request a free trial.

SetPoint Medical Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

SetPoint Medical Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

SetPoint Medical Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Action Potential Venture CapitalVenture CapitalMinority000 0000000 0000
Boston ScientificCorporationMinority000 0000000 0000
Covidien VenturesCorporate Venture CapitalMinority000 0000000 0000
Foundation Medical ManagementCorporate Venture CapitalMinority000 0000000 0000
GlaxoSmithKlineCorporationMinority000 0000000 0000
Action Potential Venture Capital Venture Capital
Boston Scientific Corporation
Covidien Ventures Corporate Venture Capital
Foundation Medical Management Corporate Venture Capital
GlaxoSmithKline Corporation

SetPoint Medical Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Anthony ArnoldPresident, Chief Executive Officer & Board Member
Mike FaltysChief Technology Officer
Kevin Tracey MDScientific Co-Founder
Shaw Warren MDScientific Co-Founder
Ralph ZitnikChief Medical Officer
Anthony Arnold President, Chief Executive Officer & Board Member
Mike Faltys Chief Technology Officer
Kevin Tracey MD Scientific Co-Founder
Shaw Warren MD Scientific Co-Founder
Ralph Zitnik Chief Medical Officer

SetPoint Medical Board Members (9)

NameRepresentingRoleSinceContact
Info
Allan WillSelfChairman000 0000
Andrew Firlik MDSelfBoard Member000 0000
Anthony ArnoldSetPoint MedicalPresident, Chief Executive Officer & Board Member000 0000
Bill GearyFoundation Medical ManagementBoard Member000 0000
Christopher KasterSelfBoard Member000 0000
Allan Will Chairman Self
Andrew Firlik MD Board Member Self
Anthony Arnold President, Chief Executive Officer & Board Member SetPoint Medical
Bill Geary Board Member Foundation Medical Management
Christopher Kaster Board Member Self
Request full access to PitchBook